Product Launch Announcement: Epag 50 (Eltrombopag Olamine 50mg) tablets
We are proud to introduce Epag 50 contains Eltrombopag Olamine 50mg, an oral thrombopoietin receptor agonist (TPO-RA) used to increase platelet production in patients with selected hematological disorders. It is indicated for appropriate patients with chronic immune thrombocytopenia (ITP), severe aplastic anemia (SAA), and certain cases of thrombocytopenia associated with chronic hepatitis C, in accordance with approved prescribing information. Epag 50 is manufactured to stringent pharmaceutical quality standards, ensuring consistent quality, safety, and reliability.
🔍 Product Overview
Generic Name: Eltrombopag Olamine
Strength: 50mg
Formulation: Tablets
Primary Indications:
Epag 50 (Eltrombopag Olamine 50mg) tablets is indicated for:
- Chronic Immune Thrombocytopenia (ITP) in patients with insufficient response to corticosteroids, immunoglobulins, or splenectomy, where indicated.
- Severe Aplastic Anemia (SAA) in appropriate treatment settings.
- Thrombocytopenia associated with chronic hepatitis C to allow initiation and maintenance of interferon-based therapy, where approved.
- Use only under the supervision of a qualified hematologist or healthcare professional.
Mechanism of Action:
Eltrombopag is a thrombopoietin receptor agonist (TPO-RA) that stimulates the thrombopoietin (TPO) receptor on bone marrow progenitor cells, promoting the production and maturation of megakaryocytes and increasing platelet production.
💡 Key Benefits
- Stimulates platelet production through targeted TPO receptor activation.
- Effective oral therapy for selected thrombocytopenic disorders.
- Convenient once-daily oral tablet.
- Clinically established efficacy in approved indications.
- Manufactured under stringent quality standards for consistent safety and reliability.
🎯 Target Audience
- Hematologists
- Medical Oncologists
- Internal Medicine Specialists
- Transplant Specialists
- Hospitals and Hematology Centers
- Specialty Pharmacies
🏥 Commitment to Clinical Excellence
Epag 50 is developed with a commitment to delivering high-quality hematology therapies that meet global quality standards. Manufactured in compliance with Good Manufacturing Practices (GMP), every batch undergoes rigorous quality testing to ensure safety, consistency, and reliability. We are dedicated to supporting healthcare professionals with trusted therapeutic solutions that improve patient care.
📦 Availability
Epag 50 (Eltrombopag Olamine 50mg) tablets are available through authorized distributors and healthcare supply channels. For supply inquiries, bulk orders, or regulatory documentation, please contact our sales or distribution team.
Epag 50 – Restoring Platelets. Renewing Possibilities.
